Effect of clinofibrate, a new hypolipidemic agent, on biliary and serum lipids in patients with hyperlipidemia.

[1]  M. Kohlmeier,et al.  Biliary and plasma lipids and lipid-lowering chemotherapy Studies with clofibrate, fenofibrate and etofibrate in healthy volunteers , 1980 .

[2]  M. Karvonen,et al.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. , 1979, British heart journal.

[3]  K. Einarsson,et al.  Biliary lipid composition during treatment with different hypolipidaemic drugs * , 1979, European journal of clinical investigation.

[4]  S. Grundy,et al.  Risk factors for the development of cholelithiasis in man (second of two parts). , 1978, The New England journal of medicine.

[5]  D. Grafnetter,et al.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators. , 1978, British heart journal.

[6]  S. Grundy,et al.  Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia. , 1977, The Journal of laboratory and clinical medicine.

[7]  K. Suzuki,et al.  Effects of S-8527 (1,1-bis4'-(1"-carboxy'1"-methylpropoxy)-phenyl)-cyclohexane), a new hypolipidemic compound, on triglyceride metablolism in rats. , 1975, Biochemical pharmacology.

[8]  M. Oliver,et al.  CLOFIBRATE AND GALLSTONES , 1975, The Lancet.

[9]  E. H. Ahrens,et al.  Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man. , 1974, Gastroenterology.

[10]  A. Hofmann,et al.  Letter: A simple calculation of the lithogenic index of bile: expressing biliary lipid composition on rectangular coordinates. , 1973, Gastroenterology.

[11]  H. Nakatani,et al.  Hypolipidemic action of a new aryloxy compound (S-8527) in rats. , 1973, Atherosclerosis.

[12]  S. Sakamoto,et al.  Morphological changes in the liver of rats treated with a new hypolipidemic agent, S-8527. , 1973, Atherosclerosis.

[13]  M. Olszewski,et al.  Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man. , 1973, The Journal of clinical investigation.

[14]  Heady Ja.  A cooperative trial on the primary prevention of ischaemic heart disease using clofibrate: design, methods, and progress. , 1973 .

[15]  J. Thistle,et al.  Induced alterations in composition of bile of persons having cholelithiasis. , 1971, Gastroenterology.

[16]  F. Hegardt,et al.  The solubility of cholesterol in aqueous solutions of bile salts and lecithin , 1971, Zeitschrift fur Ernahrungswissenschaft.

[17]  K. Miyata,et al.  Effects of estradiol, dietary cholesterl and 1-thyroxine on biliary bile acid composition and secretory rate, and on plasma, liver and bile cholesterol levels in rats. , 1970, Endocrinologia japonica.

[18]  L. Turnberg,et al.  The quantitative determination of bile salts in bile using thin-layer chromatography and 3 alpha-hydroxysteroid dehydrogenase. , 1969, Clinica chimica acta; international journal of clinical chemistry.

[19]  D. Small,et al.  The physicochemical basis of cholesterol gallstone formation in man. , 1968, The Journal of clinical investigation.

[20]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.